24 results on '"Weycker D"'
Search Results
2. EE490 Attributable Cost of Adult Respiratory Syncytial Virus Illness Beyond the Acute Phase
3. EE204 Budgetary Impact of New Recommendations for Pneumococcal Vaccination of US Adults
4. Taux d’hémoglobine et complications chez les patients drépanocytaires – analyse à partir d’une large base de données de santé
5. Abstract No. 159 Two sides of the coin: the need for specific treatment of edema after venous interventions in advanced chronic venous insufficiency and lymphedema
6. Expérience en vie réelle du voxelotor dans la prise en charge des complications de la drépanocytose
7. PMU22 Cost of Inotersen and Patisiran for the Treatment of Adults with Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Canada, Germany, and Italy
8. PCN156 USE OF G-CSF PROPHYLAXIS AND INCIDENCE OF FEBRILE NEUTROPENIA AMONG MEDICARE BENEFICIARIES RECEIVING CHEMOTHERAPY IN TRADITIONAL AND ALTERNATIVE PAYMENT MODELS
9. PND52 ECONOMIC BURDEN OF AN ACUTE RELAPSE DUE TO NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)
10. PCV36 HEALTHCARE EXPENDITURES IN PATIENTS RECEIVING PHARMACOTHERAPY WITH APIXABAN OR WARFARIN FOR VENOUS THROMBOEMBOLISM (VTE): A COMPARATIVE STUDY
11. Phase III Trial of Recombinant Human Parathyroid Hormone in Hypoparathyroidism: A Post-HOC Analysis of Change in Health-State Utility Among Responders
12. Déclin de la capacité vitale forcée selon l’extension radiologique de l’emphysème au cours du syndrome emphysème-fibrose
13. Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Patients Aged 65-84 Years With Co-Morbidities or Immunosuppression In Belgium
14. Déclin de la fonction pulmonaire en fonction de l’imagerie au cours de la fibrose pulmonaire idiopathique et du syndrome emphysème–fibrose
15. Excess Risks And Costs Of Invasive Pneumococcal Disease And Pneumonia Among Us Persons With Underlying Medical Conditions
16. PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy: A German Statutory Health Insurance Perspective
17. PSY19 Economic Costs of Chemotherapy-Induced Febrile Neutropenia Among Patients with Non-Hodgkin'S Lymphoma in European Clinical Practice
18. Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US
19. PCN58 HEALTH CARE COSTS IN WOMEN WITH INCIDENT METASTATIC BREAST CANCER RECEIVING CHEMOTHERAPY AS THEIR PRINCIPAL TREATMENT MODALITY
20. PMH32 ACAMPROSATE IN TREATMENT OF ALCOHOL DEPENDENCE-ECONOMIC BENEFITS REVISITED
21. Cost of neutropenic complications of chemotherapy
22. PMH29 ECONOMIC BURDEN OF ALCOHOLISM AND ALCOHOL ABUSE IN A US MANAGED-CARE SETTING
23. PMH30 HEALTH CARE BURDEN OF PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME
24. PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.